InnoCore Pharmaceuticals has named Jan Hendriks chief executive officer. He will take over this position from co-founder Theo Flipsen who will continue his involvement in InnoCore Pharmaceuticals as president of the company.

Hendriks brings over 20 years of experience in the pharmaceutical arena to InnoCore. He previously served as CEO of Pharma Bio-Research. He is also founder of HendRx Health.

“Jan has the right skills and experience to guide InnoCore Pharmaceuticals to its next stage, where we want to further develop and commercialize our polymeric drug delivery technologies and pharmaceutical development capabilities,” says Theo Flipsen.